BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 27573375)

  • 1. The Nicotinic α6-Subunit Selective Antagonist bPiDI Reduces Alcohol Self-Administration in Alcohol-Preferring Rats.
    Srisontiyakul J; Kastman HE; Krstew EV; Govitrapong P; Lawrence AJ
    Neurochem Res; 2016 Dec; 41(12):3206-3214. PubMed ID: 27573375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of α4- and α6-containing nicotinic receptors in the acquisition and maintenance of nicotine self-administration.
    Madsen HB; Koghar HS; Pooters T; Massalas JS; Drago J; Lawrence AJ
    Addict Biol; 2015 May; 20(3):500-12. PubMed ID: 24750355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement.
    Beckmann JS; Meyer AC; Pivavarchyk M; Horton DB; Zheng G; Smith AM; Wooters TE; McIntosh JM; Crooks PA; Bardo MT; Dwoskin LP
    Neurochem Res; 2015 Oct; 40(10):2121-30. PubMed ID: 26227997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse.
    Wooters TE; Smith AM; Pivavarchyk M; Siripurapu KB; McIntosh JM; Zhang Z; Crooks PA; Bardo MT; Dwoskin LP
    Br J Pharmacol; 2011 May; 163(2):346-57. PubMed ID: 21232049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α6β2 nicotinic acetylcholine receptors influence locomotor activity and ethanol consumption.
    Kamens HM; Peck C; Garrity C; Gechlik A; Jenkins BC; Rajan A
    Alcohol; 2017 Jun; 61():43-49. PubMed ID: 28457669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic α6β2* antagonist r-bPiDI.
    Maggio SE; Saunders MA; Nixon K; Prendergast MA; Zheng G; Crooks PA; Dwoskin LP; Bell RL; Bardo MT
    Drug Alcohol Depend; 2018 Dec; 193():154-161. PubMed ID: 30384323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats.
    Brown RM; Khoo SY; Lawrence AJ
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):2067-79. PubMed ID: 23601187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats.
    Maggio SE; Saunders MA; Baxter TA; Nixon K; Prendergast MA; Zheng G; Crooks P; Dwoskin LP; Slack RD; Newman AH; Bell RL; Bardo MT
    Psychopharmacology (Berl); 2018 May; 235(5):1439-1453. PubMed ID: 29455292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats.
    Moorman DE; James MH; Kilroy EA; Aston-Jones G
    Brain Res; 2017 Jan; 1654(Pt A):34-42. PubMed ID: 27771284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α5GABA
    Chandler CM; Reeves-Darby J; Jones SA; McDonald JA; Li G; Rahman MT; Cook JM; Platt DM
    Psychopharmacology (Berl); 2019 Jun; 236(6):1797-1806. PubMed ID: 30637435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of blockade of α4β2 and α7 nicotinic acetylcholine receptors on cue-induced reinstatement of nicotine-seeking behaviour in rats.
    Liu X
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):105-16. PubMed ID: 23953129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of alcohol taking and seeking by antagonism at α4β2 and α3β4 nAChRs.
    Cippitelli A; Brunori G; Schoch J; Armishaw CJ; Wu J; Zaveri NT; Giulianotti MA; Welmaker GS; Toll L
    Psychopharmacology (Berl); 2018 Jun; 235(6):1745-1757. PubMed ID: 29572652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats.
    Neugebauer NM; Zhang Z; Crooks PA; Dwoskin LP; Bardo MT
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):426-34. PubMed ID: 16220336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relaxin-3 receptor (Rxfp3) gene deletion reduces operant sucrose- but not alcohol-responding in mice.
    Walker AW; Smith CM; Gundlach AL; Lawrence AJ
    Genes Brain Behav; 2015 Nov; 14(8):625-34. PubMed ID: 26278401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of subunit selective nACh receptors on operant ethanol self-administration and relapse-like ethanol-drinking behavior.
    Kuzmin A; Jerlhag E; Liljequist S; Engel J
    Psychopharmacology (Berl); 2009 Mar; 203(1):99-108. PubMed ID: 18987848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glycine transporter 1 attenuates nicotine- but not food-induced cue-potentiated reinstatement for a response previously paired with sucrose.
    Uslaner JM; Drott JT; Sharik SS; Theberge CR; Sur C; Zeng Z; Williams DL; Hutson PH
    Behav Brain Res; 2010 Feb; 207(1):37-43. PubMed ID: 19799936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats.
    de Bruin NM; Lange JH; Kruse CG; Herremans AH; Schoffelmeer AN; van Drimmelen M; De Vries TJ
    Behav Brain Res; 2011 Mar; 217(2):408-15. PubMed ID: 21074574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinic acetylcholine receptors in the ventral tegmental area mediate the dopamine activating and reinforcing properties of ethanol cues.
    Löf E; Olausson P; deBejczy A; Stomberg R; McIntosh JM; Taylor JR; Söderpalm B
    Psychopharmacology (Berl); 2007 Dec; 195(3):333-43. PubMed ID: 17703283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced AMPA receptor activity increases operant alcohol self-administration and cue-induced reinstatement.
    Cannady R; Fisher KR; Durant B; Besheer J; Hodge CW
    Addict Biol; 2013 Jan; 18(1):54-65. PubMed ID: 23126443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting effects of the α7 nicotinic receptor antagonist methyllycaconitine in different rat models of heroin reinstatement.
    Palandri J; Smith SL; Heal DJ; Wonnacott S; Bailey CP
    J Psychopharmacol; 2021 Oct; 35(10):1204-1215. PubMed ID: 33691518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.